CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade vTv Therapeutics Inc. - VTVT CFD

18.14
1.57%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.22
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 18.43
Open 18.25
1-Year Change 2333.33%
Day's Range 18.14 - 18.76
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 24, 2024 18.14 -0.11 -0.60% 18.25 18.76 18.14
Jun 21, 2024 18.43 -0.12 -0.65% 18.55 18.60 18.43
Jun 20, 2024 18.94 0.51 2.77% 18.43 19.44 18.15
Jun 18, 2024 19.62 -0.26 -1.31% 19.88 19.97 19.62
Jun 17, 2024 20.03 -0.02 -0.10% 20.05 21.65 19.88
Jun 14, 2024 20.46 -2.26 -9.95% 22.72 23.18 20.46
Jun 13, 2024 22.00 0.79 3.72% 21.21 22.36 19.51
Jun 12, 2024 20.72 1.34 6.91% 19.38 21.09 19.38
Jun 11, 2024 18.43 0.25 1.38% 18.18 18.43 18.18
Jun 10, 2024 17.89 0.00 0.00% 17.89 18.93 17.88
Jun 7, 2024 17.00 -0.53 -3.02% 17.53 17.54 16.60
Jun 6, 2024 17.53 -0.40 -2.23% 17.93 18.30 17.53
Jun 5, 2024 18.93 -2.49 -11.62% 21.42 21.42 18.87
Jun 4, 2024 21.02 -0.41 -1.91% 21.43 21.43 20.92
Jun 3, 2024 21.92 -1.09 -4.74% 23.01 23.24 21.92
May 31, 2024 23.01 -0.16 -0.69% 23.17 23.61 23.01
May 30, 2024 23.68 0.02 0.08% 23.66 23.91 23.23
May 29, 2024 23.66 -0.45 -1.87% 24.11 24.41 22.95
May 28, 2024 24.57 -2.34 -8.70% 26.91 27.00 24.47
May 24, 2024 27.13 0.23 0.86% 26.90 28.36 26.90

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

vTv Therapeutics Inc. Company profile

About vTv Therapeutics Inc

vTv Therapeutics Inc. is a clinical-stage pharmaceutical company that is engaged in the discovery and development of orally administered small molecule drug candidates. It is developing a program for the treatment of type I diabetes TTP399 and for psoriasis HPP737. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. The Company is also conducting a multiple ascending dose Phase I study of HPP737, an orally administered phosphodiesterase type IV inhibitor, to assess the pharmacokinetics, pharmacodynamics, safety and tolerability of HPP737 in healthy volunteers as part of its psoriasis program. Its TTP273 is an oral, small molecule, glucagon-like peptide I (GLP-1) receptor agonist being evaluated for the treatment of type II diabetes mellitus.

Financial summary

BRIEF: For the nine months ended 30 September 2021, vTv Therapeutics Inc revenues increased from $15K to $4M. Net loss decreased 38% to $5.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other (expense) income increase from $0K to $1.8M (income), Research and Development - Balancing decrease of 10% to $7.4M (expense).

Industry: Bio Therapeutic Drugs

3980 Premier Dr
Suite 310
27265

News

Bank of England preview: no rate cut just yet despite CPI returning to 2%

The Bank of England (BoE) is widely expected to keep rates unchanged when it meets on Thursday. Analyst Daniela Harthorn looks at what this could mean

12:45, 18 June 2024

RBA Meeting Preview: No change to policy expected, markets look for fresh guidance

The Reserve Bank of Australia is expected to keep interest rates unchanged at 4.35% when it meets on Tuesday, June 18th, 2024, at 2:30 PM (AEST).

13:17, 17 June 2024

FOMC Decision Review: Rates unchanged as central bank raises inflation and interest rate forecasts

The FOMC left Federal Funds Rate unchanged at a target range of 5.25 to 5.50%.

10:55, 17 June 2024

Bank of Japan Preview: Markets look for guidance from BOJ about timing of next hike

The Bank of Japan meets on Friday, 14th of June, 2024. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

11:05, 12 June 2024

FOMC preview: Still expecting three rate cuts in 2024?

The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?

08:20, 11 June 2024

US Non-Farm Payrolls Preview: Forecasts point to a stable labour market

US labour market conditions are expected to have remained stable in May. The latest Non-Farm Payrolls data will be released on Friday, June 7th, 2024, and will provide a health check on the US jobs market.

10:09, 5 June 2024

AUD/USD analysis: Focus turns to GDP data after unexpected CPI rise

Higher-than-expected monthly CPI data watered down expectations for RBA interest rate cuts in 2024; the markets will now shift attention to quarterly GDP data on Wednesday, June 5.

15:57, 4 June 2024

People also watch

BTC/USD

61,259.75 Price
+2.920% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

ETH/USD

3,375.81 Price
+1.940% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.48 Price
+1.830% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

19,573.50 Price
+0.490% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 620,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading